Hurler Disease Bone Marrow Stromal Cells Exhibit Altered Ability to Support Osteoclast Formation

被引:25
作者
Gatto, Francesca [1 ]
Redaelli, Daniela [1 ]
Salvade, Agnese
Marzorati, Simona [1 ]
Sacchetti, Benedetto [3 ]
Ferina, Chiara [1 ]
Roobrouck, Valerie D. [4 ]
Bertola, Francesca [5 ]
Romano, Michela [6 ]
Villani, Guglielmo [7 ]
Antolini, Laura [8 ]
Rovelli, Attilio
Verfaillie, Catherine M. [4 ]
Biondi, Andrea
Riminucci, Mara [3 ]
Bianco, Paolo [3 ]
Serafini, Marta [1 ,2 ]
机构
[1] Univ Milano Bicocca, Dept Pediat, Dulbecco Telethon Inst, Tettamanti Res Ctr, I-20900 Monza, Italy
[2] Univ Milano Bicocca, Dept Pediat, Dulbecco Telethon Inst, Tettamanti Res Ctr,San Gerardo Hosp, I-20900 Monza, Italy
[3] Univ Roma La Sapienza, Dept Mol Med, Rome, Italy
[4] Katholieke Univ Leuven, Stem Cell Inst, Louvain, Belgium
[5] Univ Milano Bicocca, Consortium Human Mol Genet, I-20900 Monza, Italy
[6] Ist Ric Farmacol Mario Negri, Flow Cytometry Unit, Dept Oncol, Milan, Italy
[7] Univ Naples Federico II, Dept Biochem & Med Biotechnol, Naples, Italy
[8] Univ Milano Bicocca, Ctr Biostat, Dept Clin Med & Prevent, I-20900 Monza, Italy
关键词
MESENCHYMAL STEM-CELLS; MUCOPOLYSACCHARIDOSIS TYPE-I; LYSOSOMAL STORAGE DISORDERS; ALPHA-L-IDURONIDASE; MUSCULOSKELETAL MANIFESTATIONS; JOINT DISEASE; DIFFERENTIATION; TRANSPLANTATION; OSTEOPOROSIS; FIBROBLASTS;
D O I
10.1089/scd.2011.0555
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Mucopolysaccharidosis type I (MPS IH; Hurler syndrome) is a rare genetic disorder that is caused by mutations in the alpha-L-iduronidase (IDUA) gene, resulting in the deficiency of IDUA enzyme activity and intra-cellular accumulation of glycosaminoglycans. A characteristic skeletal phenotype is one of the many clinical manifestations in Hurler disease. Since the mechanism(s) underlying these skeletal defects are not completely understood, and bone and cartilage are mesenchymal lineages, we focused on the characterization of mesenchymal cells isolated from the bone marrow (BM) of 5 Hurler patients. IDUA-mutated BM stromal cells (BMSC) derived from MPS IH patients exhibited decreased IDUA activity, consistent with the disease genotype. The expansion rate, phenotype, telomerase activity, and differentiation capacity toward adipocytes, osteoblasts, chondrocytes, and smooth muscle cells in vitro of the MPS I BMSC lines were similar to those of BMSC from age-matched normal control donors. MPS I BMSC also had a similar in vivo osteogenic capacity as normal BMSC. However, MPS I BMSC displayed an increased capacity to support osteoclastogenesis, which may correlate with the up-regulation of the RANKL/RANK/OPG molecular pathway in MPS I BMSC compared with normal BMSC.
引用
收藏
页码:1466 / 1477
页数:12
相关论文
共 45 条
[31]  
Russell C, 1998, CLIN GENET, V53, P349
[32]   Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment [J].
Sacchetti, Benedetto ;
Funari, Alessia ;
Michienzi, Stefano ;
Di Cesare, Silvia ;
Piersanti, Stefania ;
Saggio, Isabella ;
Tagliafico, Enrico ;
Ferrari, Stefano ;
Robey, Pamela Gehron ;
Riminucci, Mara ;
Bianco, Paolo .
CELL, 2007, 131 (02) :324-336
[33]   GMP-grade preparation of biomimetic scaffolds with osteo-differentiated autologous mesenchymal stromal cells for the treatment of alveolar bone resorption in periodontal disease [J].
Salvade, A. ;
Belotti, D. ;
Donzelli, E. ;
D'Amico, G. ;
Gaipa, G. ;
Renoldi, G. ;
Carini, F. ;
Baldoni, M. ;
Pogliani, E. M. ;
Tredici, G. ;
Biondi, A. ;
Biagi, E. .
CYTOTHERAPY, 2007, 9 (05) :427-438
[34]   Mechanisms of disease: the link between RANKL and arthritic bone disease [J].
Schett, G ;
Hayer, S ;
Zwerina, J ;
Redlich, K ;
Smolen, JS .
NATURE CLINICAL PRACTICE RHEUMATOLOGY, 2005, 1 (01) :47-54
[35]  
SILVERI CP, 1991, CLIN ORTHOP RELAT R, P305
[36]   Mechanism of glycosaminoglycan-mediated bone and joint disease - Implications for the mucopolysaccharidoses and other connective tissue diseases [J].
Simonaro, Calogera M. ;
D'Angelo, Marina ;
He, Xingxuan ;
Eliyahu, Efrat ;
Shtraizent, Nataly ;
Haskins, Mark E. ;
Schuchman, Edward H. .
AMERICAN JOURNAL OF PATHOLOGY, 2008, 172 (01) :112-122
[37]   Involvement of the Toll-like receptor 4 pathway and use of TNF-α antagonists for treatment of the mucopolysaccharidoses [J].
Simonaro, Calogera M. ;
Ge, Yi ;
Eliyahu, Efrat ;
He, Xingxuan ;
Jepsen, Karl J. ;
Schuchman, Edward H. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (01) :222-227
[38]   Joint and bone disease in mucopolysaccharidoses VI and VII: Identification of new therapeutic targets and biomarkers using animal models [J].
Simonaro, CM ;
D'Angelo, M ;
Haskins, ME ;
Schuchman, EH .
PEDIATRIC RESEARCH, 2005, 57 (05) :701-707
[39]   Articular chondrocytes from animals with a dermatan sulfate storage disease undergo a high rate of apoptosis and release nitric oxide and inflammatory cytokines: A possible mechanism underlying degenerative joint disease in the mucopolysaccharidoses [J].
Simonaro, CM ;
Haskins, ME ;
Schuchman, EH .
LABORATORY INVESTIGATION, 2001, 81 (09) :1319-1328
[40]   Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis [J].
Stenderup, K ;
Justesen, J ;
Eriksen, EF ;
Rattan, SIS ;
Kassem, M .
JOURNAL OF BONE AND MINERAL RESEARCH, 2001, 16 (06) :1120-1129